
Photo taken from Drew Moghanaki/X
Mar 5, 2024, 14:28
Drew Moghanaki: A critical report from Amsterdam demonstrates misdiagnosed drug-related pneumonitis
Drew Moghanaki, Professor, Chief of Thoracic Oncology at UCLA Department of Radiation Oncology, recently shared on X/Twitter:
“A critical report from Amsterdam demonstrates how often drug-related pneumonitis can be misdiagnosed in patients receiving thoracic radiation therapy. When it occurs, it can lead to premature termination of life-prolonging checkpoint inhibitors.
Access to radiation therapy treatment plans can make all the difference when trying to determine whether radiographic abnormalities on surveillance CT scans represent a harbinger of symptomatic drug-induced pneumonitis versus just an asymptomatic remnant of beam tracks.”
Source: Drew Moghanaki/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10
Feb 22, 2025, 13:04
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22